Barclays and Unreasonable,select 1mg Technologies to receive $100,000


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ barclays-unreasonable-selects-top-innovations
Unreasonable Impact is an innovative multi-year multi-geographic partnership between Barclays and Unreasonable Group to support entrepreneurs

1mg Technologies has been awarded a $100,000 grant in recognition of the exceptional work being undertaken in addressing the immediate and long term challenges resulting from the effects of the global pandemic.

Unreasonable Impact COVID-19 Response is a new initiative launched by Barclays and Unreasonable Group awarding $100,000 grants each to ten Unreasonable ventures that have pivoted their businesses to combat challenges related to COVID-19. The grant is designed to support and amplify the impact of the work 1mg Technologies is doing.

The initiative was launched as a direct response to the outbreak of COVID-19 and is an extension of Unreasonable Impact, the unique multi-year partnership between the two companies supporting growth-stage entrepreneurs across the Americas, Europe and Asia Pacific regions solving many of the world's most pressing issues.

1mg was chosen by a selection committee for the meaningful work they are doing in India of ensuring access to healthcare essential services at home such as the delivery of medicines at home for millions of families in India, COVID-19 testing, etc. 1mg is helping families stay at home and stay safe. Prashant Tandon, 1mg's Co-founder & CEO said, "We are extremely happy to receive this global recognition and grant. Our frontliners are working non-stop amidst the pandemic to ensure millions of families have access to healthcare services at their doorsteps. Our courageous fleet of frontliners continues to serve our nation selflessly and this recognition further strengthens our belief in the advantages of digital-led healthcare models."

1mg's Co-founder & CEO will join the nine other recipients at a live virtual event, The Unreasonable Impact COVID-19 Response Global Summit, created with Barclays on July 8th where he will have a chance to share his team's exceptional work with a global audience.

Joe McGrath, Barclays' Global Head of Banking, commented, "Through Unreasonable Impact, we set out to help entrepreneurs take their businesses to the next level. They are already tackling almost impossible-sounding challenges, so when COVID-19 took hold we weren't surprised that they would point their talent and drive towards responding to the pandemic. We're in awe of the speed that they've pivoted their businesses and of the positive impact that they've already made, so we're delighted to be able to support them through the Unreasonable Impact COVID-19 Response."

Daniel Epstein, Founder and CEO of Unreasonable Group, added, "Unreasonable Impact was co-created with Barclays with a shared intention to support and scale up entrepreneurial solutions to the world's most pressing challenges. The global impact of COVID-19 is unlike any challenge any of us has seen in our lifetimes. Setting up the COVID-Response to support and amplify ventures leveraging business to combat challenges related to the pandemic is a natural extension of our mission. We are humbled to be supporting the exceptional workof1mg Technologies."

Full list of ventures selected:

1MG Technologies: India's leading mobile healthcare platform with over 9 million downloads and 33 million monthly visits

80 Acres Farms: Converting urban spaces in ultra-efficient indoor farms that produce accessible, tasty and affordable local food year-round

Airlabs: Transforming polluted cities into clean air zones by removing 95% nitrogen dioxide along with all other pollutants from the air

Day Owl: Turning trash from the poorest neighborhoods in the world into purpose-filled recycled fabrics

Ecoware: Creating 100% biodegradable eco-friendly and compostable certified food packaging and garbage bags

eFishery: Creating the future of aquaculture with an IoT smart feeding technology to help hundreds of millions of farmers at the bottom of the pyramid

Globechain: Creating the world's largest reuse marketplace that connects corporates to charities and people to redistribute unwanted items

Nanobiosym: Using nanotechnology to empower people worldwide with rapid affordable and portable diagnostic information about their own health

Olio: connecting neighbors and local shops so surplus food and other household items can be shared rather than thrown away

Zero Mass: Making drinking water an ultimate resource with SOURCE, a set of panels that make water from the air

Tags : #BarclaysBank #UnreasonableImpact #NewInitiative #TopInnovations #1mgTechnologies

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026